Colour theme
Theme
Sign in
Insider · CIK 0001620743

Keating Laurie

CIK 0001620743 Name as filed on the most recent filing

Filed as Keating Laurie (19)

45 transaction lines · from 19 filings · filed 2017-05-31 to 2023-01-19 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

45 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2022-05-16 Immuneering Corp
IMRX
P, Open-market purchase 7,000 acquired 5.00 35,000.00 Form 4, filing 0001415889-22-005150
2022-05-06 PepGen Inc.
PEPG
P, Open-market purchase 4,166 acquired 12.00 49,992.00 Form 4, filing 0001127602-23-001831
2021-08-05 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 10,000 disposed 188.95 1,889,500.00 Form 4, filing 0001735276-21-000079
2021-08-03 Immuneering Corp
IMRX
P, Open-market purchase 7,000 acquired 15.00 105,000.00 Form 4, filing 0001104659-21-099736
2021-07-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 5,000 disposed 178.95 894,750.00 Form 4, filing 0001735276-21-000053
2021-07-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 1,812 disposed 179.00 324,348.00 Form 4, filing 0001735276-21-000053
2021-06-09 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 1,734 disposed 154.00 267,036.00 Form 4, filing 0001735276-21-000047
2021-01-13 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 5,000 disposed 169.00 845,000.00 Form 4, filing 0001735276-21-000006
2021-01-13 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 3,000 disposed 170.00 510,000.00 Form 4, filing 0001735276-21-000006
2021-01-13 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 1,027 disposed 174.00 178,698.00 Form 4, filing 0001735276-21-000006
2021-01-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 11,941 disposed 159.00 1,898,619.00 Form 4, filing 0001735276-21-000004
2021-01-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 3,000 disposed 165.00 495,000.00 Form 4, filing 0001735276-21-000004
2021-01-11 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 758 disposed 154.00 116,732.00 Form 4, filing 0001735276-21-000004
2020-07-13 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 15,618 disposed 161.32 2,519,495.76 Form 4, filing 0001735276-20-000090
2020-07-13 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 14,236 disposed 160.52 2,285,162.72 Form 4, filing 0001735276-20-000090
2020-07-13 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 9,530 disposed 162.24 1,546,147.20 Form 4, filing 0001735276-20-000090
2020-07-13 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 4,482 disposed 157.16 704,391.12 Form 4, filing 0001735276-20-000090
2020-07-13 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 2,323 disposed 158.27 367,661.21 Form 4, filing 0001735276-20-000090
2020-07-13 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 1,061 disposed 159.22 168,932.42 Form 4, filing 0001735276-20-000090
2020-04-20 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 10,000 disposed 139.00 1,390,000.00 Form 4, filing 0001735276-20-000056
2020-02-10 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 10,000 disposed 129.00 1,290,000.00 Form 4, filing 0001735276-20-000014
2020-01-29 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 6,337 disposed 119.00 754,103.00 Form 4, filing 0001735276-20-000004
2020-01-27 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 13,631 disposed 116.43 1,587,057.33 Form 4, filing 0001735276-20-000002
2020-01-27 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 13,084 disposed 118.61 1,551,893.24 Form 4, filing 0001735276-20-000002
2020-01-27 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 6,667 disposed 119.53 796,906.51 Form 4, filing 0001735276-20-000002
2020-01-27 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 4,100 disposed 117.67 482,447.00 Form 4, filing 0001735276-20-000002
2020-01-27 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 3,365 disposed 115.55 388,825.75 Form 4, filing 0001735276-20-000002
2020-01-27 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 190 disposed 120.21 22,839.90 Form 4, filing 0001735276-20-000002
2018-06-20 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 1,563 disposed 105.04 164,177.52 Form 4, filing 0001735276-18-000035
2018-03-20 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 500 disposed 149.97 74,985.00 Form 4, filing 0001553878-18-000029
2018-03-20 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 462 disposed 147.79 68,278.98 Form 4, filing 0001553878-18-000029
2018-03-20 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 300 disposed 152.79 45,837.00 Form 4, filing 0001553878-18-000029
2018-03-20 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 200 disposed 151.48 30,296.00 Form 4, filing 0001553878-18-000029
2018-03-20 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 100 disposed 146.36 14,636.00 Form 4, filing 0001553878-18-000029
2018-03-13 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 10,000 disposed 150.00 1,500,000.00 Form 4, filing 0001553878-18-000023
2018-03-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 10,000 disposed 140.00 1,400,000.00 Form 4, filing 0001553878-18-000023
2017-12-20 Alnylam Pharmaceuticals, Inc.
ALKS
S, Open-market sale 4,049 disposed 120.88 489,456.48 Form 4, filing 0001325812-17-000038
2017-12-20 Alnylam Pharmaceuticals, Inc.
ALKS
S, Open-market sale 1,900 disposed 121.67 231,181.93 Form 4, filing 0001325812-17-000038
2017-12-20 Alnylam Pharmaceuticals, Inc.
ALKS
S, Open-market sale 300 disposed 122.53 36,759.99 Form 4, filing 0001325812-17-000038
2017-12-01 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 9,700 disposed 136.50 1,324,050.00 Form 4, filing 0001553878-17-000070
2017-12-01 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 7,500 disposed 135.56 1,016,700.00 Form 4, filing 0001553878-17-000070
2017-12-01 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 6,199 disposed 137.29 851,060.71 Form 4, filing 0001553878-17-000070
2017-12-01 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 3,801 disposed 134.59 511,576.59 Form 4, filing 0001553878-17-000070
2017-12-01 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 2,800 disposed 133.37 373,436.00 Form 4, filing 0001553878-17-000070
2017-05-30 Alnylam Pharmaceuticals, Inc.
ALNY
P, Open-market purchase 11,500 acquired 65.35 751,502.00 Form 4, filing 0001553878-17-000015

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 4
  • Open-market sale 41
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. KEATING LAURIE, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001620743

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.